FDA Warns Four Drug Companies about Faulty Ads

The U.S. Food and Drug Administration sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The FDA demanded that Bayer, Eli Lilly (LLY), Cephalon (CEPH) and Amylin Pharmaceuticals (AMLN) stop using ads the agency says exaggerate the efficacy of a drug or downplay its risks.
Read Full Story

Can't get enough personal finance tips?

Sign up for Finance Report by AOL and get everything from consumer news to money tricks delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.